Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
38 (15%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2019-08-29 | 2019-10-26 | 92678 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2019-08-29 | 2019-10-26 | 92681 |
| ACT SUMATRIPTAN | 100MG | TABLET | Resolved | 2019-08-29 | 2020-07-10 | 92684 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 250MG | POWDER FOR SOLUTION | Resolved | 2019-09-05 | 2019-09-19 | 93110 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2019-09-05 | 2019-12-19 | 93131 |
| TEVA-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2019-09-05 | 2019-09-27 | 93134 |
| TEVA-MODAFINIL | 100MG | TABLET | Resolved | 2019-09-05 | 2019-10-04 | 93137 |
| PEMETREXED DISODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Resolved | 2019-09-05 | 2019-10-17 | 93140 |
| TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2019-09-05 | 2019-09-27 | 93143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-09-05 | 2020-02-08 | 93146 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2019-09-05 | 2020-04-09 | 93149 |
| TEVA-TOLTERODINE | 1MG | TABLET | Resolved | 2019-09-05 | 2021-07-22 | 93152 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-09-05 | 2019-10-26 | 93156 |
| TEVA-LATANOPROST | 0.05MG | SOLUTION | Resolved | 2019-09-05 | 2020-07-10 | 93159 |
| RATIO-METFORMIN | 850MG | TABLET | Resolved | 2019-09-05 | 2020-07-10 | 93162 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-09-05 | 2020-09-18 | 93166 |
| ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2019-09-05 | 2019-10-17 | 93169 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2019-09-05 | 2020-01-24 | 93172 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2019-09-12 | 2019-10-10 | 93644 |
| TEVA-DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-09-12 | 2019-11-08 | 93647 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |